NCT02924402 2024-11-13Study to Evaluate Safety and Tolerability of XmAb13676 (Plamotamab) in Patients With CD20-expressing Hematologic MalignanciesXencor, Inc.Phase 1 Completed154 enrolled
NCT00884546 2016-09-30Multiple Ascending Dose (MAD) Combination in Subjects With Multiple MyelomaBristol-Myers SquibbPhase 1 Completed27 enrolled
NCT01046864 2014-09-16Combination of Brivanib With 5-Fluorouracil/Leucovorin (5FU/LV) and 5-Fluorouracil/Leucovorin/Irinotecan (FOLFIRI)Bristol-Myers SquibbPhase 1 Completed49 enrolled